These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24417438)

  • 1. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
    Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
    J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
    Hsu WH; Wen YW; Chen LK; Hsiao FY
    Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
    Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
    Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
    Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
    Taylor-Rowan M; Kraia O; Kolliopoulou C; Noel-Storr AH; Alharthi AA; Cross AJ; Stewart C; Myint PK; McCleery J; Quinn TJ
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015196. PubMed ID: 35994403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
    Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
    Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
    Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
    Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance Between Anticholinergic Burden Scales.
    Naples JG; Marcum ZA; Perera S; Gray SL; Newman AB; Simonsick EM; Yaffe K; Shorr RI; Hanlon JT;
    J Am Geriatr Soc; 2015 Oct; 63(10):2120-4. PubMed ID: 26480974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures.
    Pont LG; Nielen JT; McLachlan AJ; Gnjidic D; Chan L; Cumming RG; Taxis K
    Br J Clin Pharmacol; 2015 Nov; 80(5):1169-75. PubMed ID: 25923961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
    Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
    Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic Medication Burden in Parkinson's Disease Outpatients.
    Nawaz H; Sargent L; Quilon H; Cloud LJ; Testa CM; Snider JD; Lageman SK; Baron MS; Berman BD; Zimmerman K; Price ET; Mukhopadhyay ND; Barrett MJ
    J Parkinsons Dis; 2022; 12(2):599-606. PubMed ID: 34806617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review on the use of anticholinergic scales in poly pathological patients.
    Villalba-Moreno AM; Alfaro-Lara ER; Pérez-Guerrero MC; Nieto-Martín MD; Santos-Ramos B
    Arch Gerontol Geriatr; 2016; 62():1-8. PubMed ID: 26518612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.
    Ruxton K; Woodman RJ; Mangoni AA
    Br J Clin Pharmacol; 2015 Aug; 80(2):209-20. PubMed ID: 25735839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anticholinergic burden of medications in older adults.
    West T; Pruchnicki MC; Porter K; Emptage R
    J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population -Differences between Four Anticholinergic Scales].
    Kimura T; Kato D; Nishimura T; Van Schyndle J; Uno S; Yoshida M
    Yakugaku Zasshi; 2020; 140(5):701-710. PubMed ID: 32378674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal associations of anticholinergic medications on cognition and possible mitigating role of physical activity.
    Norling AM; Bennett A; Crowe M; Long DL; Nolin SA; Myers T; Del Bene VA; Lazar RM; Gerstenecker A
    J Am Geriatr Soc; 2023 Jun; 71(6):1937-1943. PubMed ID: 36786273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study.
    Fox C; Richardson K; Maidment ID; Savva GM; Matthews FE; Smithard D; Coulton S; Katona C; Boustani MA; Brayne C
    J Am Geriatr Soc; 2011 Aug; 59(8):1477-83. PubMed ID: 21707557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.